A Study to Evaluate Glofitamab as Single Agent Administered After Pretreatment With Obinutuzumab in Chinese Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Clinical trial NCT04657302 · COMPLETED
Trial details
- NCT number
- NCT04657302
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-08
- Primary completion
- 2022-10-25
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.